Suppressing inflammation by inhibiting the NF-IB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia

British Journal of Pharmacology

Volumn 167, Issue 7, 2012, Pages 1520-1532

  Jiang, Teng ^a   Gao, Li ^b   Guo, Jun ^b   Lu, Jie ^b   Wang, Yao ^b   Zhang, Yingdong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

A 779; Ang (1 7); inflammation; NF IB; stroke

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN[1-7]; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; TISSUE LEVEL; UPREGULATION; WESTERN BLOTTING;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BEHAVIOR, ANIMAL; CEREBROVASCULAR CIRCULATION; IMIDAZOLES; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; MALE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84868667825     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02105.x     Document Type: Article

References (45)

1. Alexander SP, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edn. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Al-Maghrebi M, Benter IF, Diz DI, (2009). Endogenous Ang-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats. Pharmacol Res 59: 263-268.
3. Ashwal S, Tone B, Tian HR, Cole DJ, Liwnicz BH, Pearce WJ, (1998). Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 29: 1037-1046.
4. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H, (1986). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472-476.
5. Blume A, Undeutsch C, Zhao Y, Kaschina E, Culman J, Unger T, (2005). ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain. Am J Physiol Regul Integr Comp Physiol 289: 845-850.
6. Bosnyak S, Jones ES, Christopoulos A, Aguilar MI, Thomas WG, Widdop RE, (2011). Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci (Lond) 121: 297-303.
7. Brouns R, De Deyn PP, (2009). The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111: 483-495.
8. Candelario-Jalil E, Gonzalez-Falcon A, Garcia-Cabrera M, Alvarez D, Al Dalain S, Martinez G, et al,. (2003). Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J Neurochem 86: 545-555.
9. Chan SJ, Wong WS, Wong PT, Bian JS, (2010). Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia. Br J Pharmacol 161: 668-679.
10. Chappell MC, Brosnihan KB, Diz DI, Ferrario CM, (1989). Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem 264: 16518-16523.
11. Clark MA, Diz DI, Tallant EA, (2001). Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension 37: 1141-1146.
12. El-Hashim AZ, Renno WM, Raghupathy R, Abduo HT, Akhtar S, Benter IF, (2012). Angiotensin 1-7 inhibits allergic inflammation, via the Mas receptor, through suppression of ERK1/2 and NF-IB dependent pathways. Br J Pharmacol 166: 1964-1976.
13. Ferreira AJ, Santos RA, Bradford CN, Mecca AP, Sumners C, Katovich MJ, et al,. (2010). Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 55: 207-213.
14. Fu H, Hosomi N, Pelisch N, (2011). Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia. J Hypertens 29: 2210-2219.
15. Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, et al,. (2004). Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110: 843-848.
16. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
17. Kim-Mitsuyama S, Yamamoto E, Tanaka T, Zhan Y, Izumi Y, Izumiya Y, et al,. (2005). Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats. Stroke 36: 1083-1088.
18. Liao X, Wang L, Yang C, He J, Wang X, Guo R, et al,. (2011). Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia/reperfusion-induced injury through the inhibition of oxidative stress. Mol Med Report 4: 1145-1150.
19. Longa EZ, Weinstein PR, Carlson S, (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
20. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, (2006). Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
21. Lu J, Zhang Y, Shi J, (2008). Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats. Brain Res 1219: 127-135.
22. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
23. Mecca AP, Regenhardt RW, O'Connor TE, Joseph JP, Raizada MK, Katovich MJ, et al,. (2011). Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischemic stroke. Exp Physiol 96: 1084-1096.
24. Mendes AC, Ferreira AJ, Pinheiro SV, Santos RA, (2005). Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats. Regul Pept 125: 29-34.
25. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, et al,. (2004). Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35: 987-991.
26. Perkins ND, (2006). Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25: 6717-6730.
27. Raffai G, Durand MJ, Lombard JH, (2011). Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats. Am J Physiol Heart Circ Physiol 301: 1341-1352.
28. Ridder DA, Schwaninger M, (2009). NF-kappaB signaling in cerebral ischemia. Neuroscience 158: 995-1006.
29. Roks AJ, van Geel PP, Pinto YM, Buikema H, Henning RH, de Zeeuw D, et al,. (1999). Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 34: 296-301.
30. Saavedra JM, (2005). Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25: 485-512.
31. Sasaki T, Kitagawa K, Yamagata K, Takemiya T, Tanaka S, Omura-Matsuoka E, et al,. (2004). Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice. J Cereb Blood Flow Metab 24: 107-113.
32. Schulz R, Heusch G, (2006). Angiotensin II type 1 receptors in cerebral ischaemia reperfusion: initiation of inflammation. J Hypertens Suppl 24: 123-129.
33. Shwari A, Badgujar L, Phukan B, Bodhankar SL, Thakurdesai P, (2011). Protective effect of Etoricoxib against middle cerebral artery occlusion induced transient focal cerebral ischemia in rats. Eur J Pharmacol 667: 230-237.
34. Sieber MW, Claus RA, Witte OW, Frahm C, (2011). Attenuated inflammatory response in aged mice brains following stroke. Plos ONE 6: e26288.
35. da Silveira KD, Coelho FM, Vieira AT, Sachs D, Barroso LC, Costa VV, et al,. (2010). Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J Immunol 185: 5569-5576.
36. Souza LL, Costa-Neto CM, (2011). Ang-(1-7) decreases LPS-induced inflammatory response in macrophages. J Cell Physiol 227: 2117-2122.
37. Stenman E, Edvinsson L, (2004). Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35: 970-974.
38. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR, (1990). A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10: 290-293.
39. Tesanovic S, Vinh A, Gaspari TA, Casley D, Widdop RE, (2010). Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 30: 1606-1613.
40. Walters PE, Gaspari TA, Widdop RE, (2005). Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension 45: 960-966.
41. Xia H, Suda S, Bindom S, Feng Y, Gurley SB, Seth D, et al,. (2011). ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. Plos ONE 6: e22682.
42. Xu P, Sriramula S, Lazartigues E, (2011). ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol 300: 804-817.
43. Zhang HL, Xu M, Wei C, Qin AP, Liu CF, Hong LZ, et al,. (2011). Protective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-IB signaling pathway. Neuroscience 176: 381-395.
44. Zhang Y, Lu J, Shi J, Lin X, Dong J, Zhang S, et al,. (2008). Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats. Neuropeptides 42: 593-600.
45. Zhu J, Jiang Y, Wu L, Lu T, Xu G, Liu X, (2012). Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience 202: 342-351.